NRx Pharmaceuticals Q2 loss narrows to $18 million
NRx Pharmaceuticals (NASDAQ:NRXP) reported a first-half 2026 net loss of $18 million versus $23.1 million a year earlier, while cash increased to $26.7 million.
NRx Pharmaceuticals (NASDAQ:NRXP) reported a first-half 2026 net loss of $18 million versus $23.1 million a year earlier, while cash increased to $26.7 million.
OLB Group (NASDAQ:OLB) reported Q2 2026 revenue of $1.28 million, down 43.6% year-over-year, while its net loss narrowed 50.3% to $1.05 million.
WeTouch Technology (NASDAQ:WETH) reported first-half 2026 revenue of $30.3 million, up 9.4%, while net income increased about 25.5% to $6 million.
Uber Technologies (NYSE:UBER) partnered with Zipline to launch autonomous Uber Eats drone deliveries in the U.S., targeting one million daily deliveries by the end of 2029.
EyePoint (NASDAQ:EYPT) said DURAVYU 2.7mg missed LUGANO’s primary BCVA endpoint against 2mg aflibercept in the full Phase 3 dataset.
Prairie Operating (NASDAQ:PROP) reported Q2 2026 revenue of $98.9 million, up approximately 45% year-over-year, while adjusted EBITDA reached $34 million.
InspireMD (NASDAQ:NSPR) reported Q2 2026 revenue of $1.77 million, down 0.4% year-over-year, while its net loss widened to $14.3 million.
Lifeward (NASDAQ:LFWD) reported Q2 2026 revenue of $6.62 million, up 16% year-over-year, while adjusted loss was $1.46 per share.
Gilat Satellite Networks (NASDAQ:GILT), through Gilat Perú, signed a $14 million agreement with Ayacucho’s regional government for a fiber-optic broadband project.
Mobix Labs (NASDAQ:MOBX) guided for fiscal Q4 2026 revenue of $1.4 million–$1.8 million, representing approximately 100% quarter-over-quarter growth at the midpoint.
GET YOUR GRAFA EDGE NOW
Sign up free to unlock this feature
We'll switch on a 30-day Edge trial as a welcome gift